What is PharmacyLive?

Compounded medications for cash-pay clinics flow through a defined stack: the prescriber writes the order, an ordering interface routes it, a 503A compounding pharmacy makes it, and a carrier ships it to the patient. PharmacyLive occupies the prescriber-facing portal layer on the pharmacy side — the software the compounder bought so doctors stop faxing. It does not compound medications, hold a pharmacy license, or sell to clinics as the primary customer.

This distinction matters when clinics evaluate their options. Questions about formulation quality, certificates of analysis, and state licensure point to the compounding pharmacy behind the portal. Questions about pricing visibility, multi-pharmacy batch checkout, and consistent UX across compounders point to whether a pharmacy-owned portal is enough — or whether your clinic needs a buyer-side layer above it.

PharmacyLive is not a clinic ordering platform you sign up for independently. Clinics do not buy PharmacyLive; they receive an invitation from a compounding pharmacy that deployed it. It is also not a multi-compounder aggregation layer — batch ordering covers multiple patients within one pharmacy's portal, not one checkout across several 503A partners.

Understanding these boundaries keeps evaluation focused. If your compounder runs PharmacyLive well and one pharmacy covers your entire formulary, their portal may be sufficient. If you route semaglutide and tirzepatide across multiple compounders and need landed cost visible before you quote cash-pay patients, that is where clinic-owned platforms like Fizy Health operate — above whatever portal software each pharmacy deployed.